\-\ Texto\\:\\ \ \(0\)\
\-\ discrete\\ 2\\ to\\ 4\\ mm\\ red\\ to\\ violaceous\\ papules\\ on\\ the\\ right\\ lower\\ extremity\\.\\ some\\ were\\ flat\\-topped\\ and\\ others\\ had\\ fine\\ white\\ scale\\.\\ there\\ were\\ skip\\ areas\\ of\\ normal\\ skin\\ between\\ the\\ lesions\\,\\ and\\ overall\\ they\\ exhibited\\ a\\ blaschkoian\\ distribution\\.\\ the\\ nails\\ and\\ mouth\\ were\\ clear\\ of\\ lesions\\,\\ and\\ no\\ similar\\ lesions\\ were\\ noted\\ anywhere\\ else\\ on\\ the\\ body\\.\ \(0\)\
\-\ the\\ patient\\ was\\ given\\ topical\\ clobetasol\\ ointment\\ to\\ apply\\ to\\ the\\ lesions\\ twice\\ per\\ day\\ for\\ two\\ weeks\\,\\ followed\\ by\\ tacrolimus\\ 0\\.1\\%\\ ointment\\ twice\\ per\\ day\\ after\\ the\\ two\\-week\\ point\\.\\ subsequent\\ phone\\ conversations\\ with\\ the\\ patient\\ revealed\\ that\\ the\\ pain\\ and\\ burning\\ have\\ decreased\\ significantly\\,\\ and\\ the\\ lesions\\ themselves\\ also\\ appear\\ to\\ be\\ resolving\\.\ \(0\)\
\-\ hepatitis\\ panel\\ was\\ negative\\ for\\ types\\ a\\,\\ b\\ and\\ c\\.\ \(0\)\
\-\ histopathology\\:\\ the\\ biopsy\\ shows\\ hyperkeratosis\\,\\ focal\\ hypergranulosis\\,\\ mild\\ acanthosis\\,\\ and\\ a\\ lichenoid\\ lymphocytic\\ infiltrate\\.\\ max\\-joseph\\ spaces\\,\\ basal\\ layer\\ alteration\\,\\ and\\ cytoid\\ bodies\\ are\\ also\\ present\\.\ \(0\)\
\-\ case\\ 3\\,\\ \\(27th\\ annual\\ uniformed\\ serivces\\ dermatology\\ seminar\\,\\ 2003\\)\\ linear\\ lichen\\ planus\ \(0\)\
\-\ 54\\ year\\-old\\ white\\ female\\ with\\ an\\ eight\\ month\\ history\\ of\\ red\\ papules\\ that\\ started\\ in\\ her\\ right\\ popliteal\\ region\\ and\\ progressively\\ spread\\ in\\ a\\ linear\\ pattern\\ to\\ involve\\ her\\ right\\ lower\\ extremity\\ from\\ the\\ buttocks\\ to\\ the\\ ankle\\.\\ the\\ lesions\\ were\\ painful\\ with\\ occasional\\ pruritus\\ and\\ burning\\ sensations\\.\\ she\\ had\\ a\\ past\\ history\\ of\\ herpes\\ zoster\\,\\ though\\ never\\ on\\ the\\ lower\\ extremities\\,\\ and\\ she\\ denied\\ any\\ preceding\\ vesicles\\ to\\ the\\ papules\\.\\ her\\ long\\ term\\ medications\\ included\\ alendronate\\,\\ estrogen\\,\\ cyclobenzaprine\\,\\ and\\ amitriptyline\\,\\ none\\ of\\ which\\ were\\ started\\ immediately\\ preceding\\ the\\ onset\\ of\\ the\\ lesion\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ papules\\:\\ 0\\.05809151797155069\ \(0\)\
\-\ lesions\\:\\ 0\\.0478235645925564\ \(0\)\
\-\ ointment\\:\\ 0\\.0469413023155865\ \(0\)\
\-\ preceding\\:\\ 0\\.04612051461066396\ \(0\)\
\-\ burning\\:\\ 0\\.04211100837440221\ \(0\)\
\-\ were\\:\\ 0\\.04056347742208895\ \(0\)\
\-\ twice\\:\\ 0\\.03796670797198623\ \(0\)\
\-\ red\\:\\ 0\\.031071843883462763\ \(0\)\
\-\ blaschkoian\\:\\ 0\\.03071609206956968\ \(0\)\
\-\ conversations\\:\\ 0\\.03071609206956968\ \(0\)\
\-\ hypergranulosis\\:\\ 0\\.03071609206956968\ \(0\)\
\-\ lichenoid\\:\\ 0\\.03071609206956968\ \(0\)\
\-\ max\\-joseph\\:\\ 0\\.03071609206956968\ \(0\)\
\-\ cytoid\\:\\ 0\\.03071609206956968\ \(0\)\
\-\ serivces\\:\\ 0\\.03071609206956968\ \(0\)\
\-\ flat\\-topped\\:\\ 0\\.028300945098977535\ \(0\)\
\-\ tacrolimus\\:\\ 0\\.028300945098977535\ \(0\)\
\-\ lichen\\:\\ 0\\.028300945098977535\ \(0\)\
\-\ alendronate\\:\\ 0\\.028300945098977535\ \(0\)\
\-\ clobetasol\\:\\ 0\\.02688817468745083\ \(0\)\
\-\ two\\-week\\:\\ 0\\.02688817468745083\ \(0\)\
\-\ her\\:\\ 0\\.026857961586950547\ \(0\)\
\-\ started\\:\\ 0\\.026561478174362642\ \(0\)\
\-\ per\\:\\ 0\\.02606511922461792\ \(0\)\
\-\ nails\\:\\ 0\\.02588579812838539\ \(0\)\
\-\ acanthosis\\:\\ 0\\.02588579812838539\ \(0\)\
\-\ linear\\:\\ 0\\.025244331519695386\ \(0\)\
\-\ phone\\:\\ 0\\.02510829446526968\ \(0\)\
\-\ hyperkeratosis\\:\\ 0\\.02510829446526968\ \(0\)\
\-\ apply\\:\\ 0\\.024473027716858685\ \(0\)\
\-\ skip\\:\\ 0\\.023935917334185312\ \(0\)\
\-\ else\\:\\ 0\\.023935917334185312\ \(0\)\
\-\ pruritus\\:\\ 0\\.023935917334185312\ \(0\)\
\-\ sensations\\:\\ 0\\.023935917334185312\ \(0\)\
\-\ amitriptyline\\:\\ 0\\.023935917334185312\ \(0\)\
\-\ zoster\\:\\ 0\\.02347065115779325\ \(0\)\
\-\ violaceous\\:\\ 0\\.02306025730533198\ \(0\)\
\-\ vesicles\\:\\ 0\\.02306025730533198\ \(0\)\
\-\ cyclobenzaprine\\:\\ 0\\.022693147494677535\ \(0\)\
\-\ themselves\\:\\ 0\\.022361056275847134\ \(0\)\
\-\ planus\\:\\ 0\\.022361056275847134\ \(0\)\
\-\ estrogen\\:\\ 0\\.022057880746266544\ \(0\)\
\-\ 0\\.1\\:\\ 0\\.021778986294442373\ \(0\)\
\-\ extremity\\:\\ 0\\.021778111286706883\ \(0\)\
\-\ exhibited\\:\\ 0\\.021520770363593168\ \(0\)\
\-\ topical\\:\\ 0\\.02027800052408539\ \(0\)\
\-\ buttocks\\:\\ 0\\.02027800052408539\ \(0\)\
\-\ alteration\\:\\ 0\\.020107999952066462\ \(0\)\
\-\ 27th\\:\\ 0\\.020107999952066462\ \(0\)\
\-\ lower\\:\\ 0\\.02008915055084177\ \(0\)\
\-\ anywhere\\:\\ 0\\.01979102511511271\ \(0\)\
\-\ white\\:\\ 0\\.019749855140850297\ \(0\)\
\-\ eight\\:\\ 0\\.019500496860969677\ \(0\)\
\-\ herpes\\:\\ 0\\.019232339923213132\ \(0\)\
\-\ lymphocytic\\:\\ 0\\.018983353985993115\ \(0\)\
\-\ day\\:\\ 0\\.018905643410124944\ \(0\)\
\-\ layer\\:\\ 0\\.018865230112558685\ \(0\)\
\-\ resolving\\:\\ 0\\.01864035721660896\ \(0\)\
\-\ popliteal\\:\\ 0\\.018041575833589243\ \(0\)\
\-\ infiltrate\\:\\ 0\\.017692852981474317\ \(0\)\
\-\ others\\:\\ 0\\.017530762334662848\ \(0\)\
\-\ panel\\:\\ 0\\.017530762334662848\ \(0\)\
\-\ never\\:\\ 0\\.017530762334662848\ \(0\)\
\-\ c\\.\\:\\ 0\\.017227586805082257\ \(0\)\
\-\ discrete\\:\\ 0\\.017155742598800944\ \(0\)\
\-\ fine\\:\\ 0\\.017155742598800944\ \(0\)\
\-\ hepatitis\\:\\ 0\\.017085349890377532\ \(0\)\
\-\ scale\\:\\ 0\\.017016351188997116\ \(0\)\
\-\ \\,\\:\\ 0\\.016978331635230565\ \(0\)\
\-\ mouth\\:\\ 0\\.016753258671547134\ \(0\)\
\-\ she\\:\\ 0\\.01671627973138796\ \(0\)\
\-\ histopathology\\:\\ 0\\.016628805422062538\ \(0\)\
\-\ seminar\\:\\ 0\\.016568207015400974\ \(0\)\
\-\ uniformed\\:\\ 0\\.01639248975537696\ \(0\)\
\-\ dermatology\\:\\ 0\\.01606559513789384\ \(0\)\
\-\ progressively\\:\\ 0\\.016013974629931677\ \(0\)\
\-\ 54\\:\\ 0\\.015719349584537728\ \(0\)\
\-\ occasional\\:\\ 0\\.015719349584537728\ \(0\)\
\-\ significantly\\:\\ 0\\.015236470966815964\ \(0\)\
\-\ types\\:\\ 0\\.01519571821502784\ \(0\)\
\-\ 2003\\:\\ 0\\.014960731173928425\ \(0\)\
\-\ annual\\:\\ 0\\.014923062476701192\ \(0\)\
\-\ overall\\:\\ 0\\.014812439834490113\ \(0\)\
\-\ immediately\\:\\ 0\\.014776332562589253\ \(0\)\
\-\ spaces\\:\\ 0\\.014670202919785389\ \(0\)\
\-\ denied\\:\\ 0\\.014500202347766463\ \(0\)\
\-\ spread\\:\\ 0\\.014402045982028844\ \(0\)\
\-\ ankle\\:\\ 0\\.014183227510812711\ \(0\)\
\-\ painful\\:\\ 0\\.014153060044808829\ \(0\)\
\-\ b\\:\\ 0\\.014034936171374399\ \(0\)\
\-\ involve\\:\\ 0\\.014034936171374399\ \(0\)\
\-\ bodies\\:\\ 0\\.013948899193707598\ \(0\)\
\-\ though\\:\\ 0\\.013810063275424672\ \(0\)\
\-\ included\\:\\ 0\\.013729341814513404\ \(0\)\
\-\ term\\:\\ 0\\.013624542318913132\ \(0\)\
\-\ basal\\:\\ 0\\.013573301387241719\ \(0\)\
\-\ distribution\\:\\ 0\\.013399669422963407\ \(0\)\
\-\ medications\\:\\ 0\\.013280739087181321\ \(0\)\
\-\ point\\:\\ 0\\.013010850379728345\ \(0\)\
\-\ had\\:\\ 0\\.012849127660213995\ \(0\)\
\-\ appear\\:\\ 0\\.012186057247812828\ \(0\)\
\-\ to\\:\\ 0\\.01190433751757453\ \(0\)\
\-\ also\\:\\ 0\\.011739509363555061\ \(0\)\
\-\ similar\\:\\ 0\\.01167835058864421\ \(0\)\
\-\ extremities\\:\\ 0\\.01167835058864421\ \(0\)\
\-\ subsequent\\:\\ 0\\.011590873511532445\ \(0\)\
\-\ skin\\:\\ 0\\.011435989321390167\ \(0\)\
\-\ pattern\\:\\ 0\\.011381332191885987\ \(0\)\
\-\ clear\\:\\ 0\\.011008803530127684\ \(0\)\
\-\ mm\\:\\ 0\\.010948415180470402\ \(0\)\
\-\ year\\-old\\:\\ 0\\.010936462096509465\ \(0\)\
\-\ they\\:\\ 0\\.010728035283927895\ \(0\)\
\-\ biopsy\\:\\ 0\\.010563391085842372\ \(0\)\
\-\ that\\:\\ 0\\.010285579989956956\ \(0\)\
\-\ long\\:\\ 0\\.010265580177117505\ \(0\)\
\-\ given\\:\\ 0\\.010207018789255548\ \(0\)\
\-\ areas\\:\\ 0\\.010018631258697097\ \(0\)\
\-\ followed\\:\\ 0\\.009982145893305823\ \(0\)\
\-\ body\\:\\ 0\\.009669908406582176\ \(0\)\
\-\ revealed\\:\\ 0\\.009555658152843531\ \(0\)\
\-\ past\\:\\ 0\\.009460625337792454\ \(0\)\
\-\ between\\:\\ 0\\.009437266676739525\ \(0\)\
\-\ right\\:\\ 0\\.009424721698018293\ \(0\)\
\-\ onset\\:\\ 0\\.009398680229704356\ \(0\)\
\-\ any\\:\\ 0\\.009375731822551546\ \(0\)\
\-\ some\\:\\ 0\\.009041561860162924\ \(0\)\
\-\ month\\:\\ 0\\.008932454845995155\ \(0\)\
\-\ negative\\:\\ 0\\.008892404743466462\ \(0\)\
\-\ decreased\\:\\ 0\\.008852809765590799\ \(0\)\
\-\ the\\:\\ 0\\.008670686845523568\ \(0\)\
\-\ two\\:\\ 0\\.008527286542216048\ \(0\)\
\-\ focal\\:\\ 0\\.008503462035325442\ \(0\)\
\-\ weeks\\:\\ 0\\.008450445145997033\ \(0\)\
\-\ region\\:\\ 0\\.008409760373656141\ \(0\)\
\-\ 4\\:\\ 0\\.008296069356024548\ \(0\)\
\-\ history\\:\\ 0\\.008224491551965737\ \(0\)\
\-\ shows\\:\\ 0\\.0081859710791947\ \(0\)\
\-\ and\\:\\ 0\\.00815371802968237\ \(0\)\
\-\ mild\\:\\ 0\\.007840604369098038\ \(0\)\
\-\ on\\:\\ 0\\.007566805007304127\ \(0\)\
\-\ none\\:\\ 0\\.0073857822540348665\ \(0\)\
\-\ noted\\:\\ 0\\.007057216684503811\ \(0\)\
\-\ 3\\:\\ 0\\.006972040162740556\ \(0\)\
\-\ \\%\\:\\ 0\\.006945369454167274\ \(0\)\
\-\ a\\:\\ 0\\.006909404212867618\ \(0\)\
\-\ was\\:\\ 0\\.006886951374311406\ \(0\)\
\-\ present\\:\\ 0\\.006724769177462303\ \(0\)\
\-\ case\\:\\ 0\\.006513952727760525\ \(0\)\
\-\ have\\:\\ 0\\.006447519436812167\ \(0\)\
\-\ 2\\:\\ 0\\.006411513925123854\ \(0\)\
\-\ after\\:\\ 0\\.006160282935920566\ \(0\)\
\-\ female\\:\\ 0\\.0061211159283896645\ \(0\)\
\-\ lesion\\:\\ 0\\.006064652355402281\ \(0\)\
\-\ patient\\:\\ 0\\.005969281748546258\ \(0\)\
\-\ which\\:\\ 0\\.00555799507750017\ \(0\)\
\-\ for\\:\\ 0\\.005080893021900454\ \(0\)\
\-\ by\\:\\ 0\\.004957738338832316\ \(0\)\
\-\ normal\\:\\ 0\\.004667639214631014\ \(0\)\
\-\ be\\:\\ 0\\.004591486840919614\ \(0\)\
\-\ there\\:\\ 0\\.0044310646566724345\ \(0\)\
\-\ from\\:\\ 0\\.004412667990084364\ \(0\)\
\-\ an\\:\\ 0\\.004117299178692438\ \(0\)\
\-\ are\\:\\ 0\\.004058793980939379\ \(0\)\
\-\ \\:\\:\\ 0\\.0039382397769709586\ \(0\)\
\-\ pain\\:\\ 0\\.0036362653920931523\ \(0\)\
\-\ no\\:\\ 0\\.00299806324287039\ \(0\)\
\-\ in\\:\\ 0\\.002936566063695156\ \(0\)\
\-\ \\(\\:\\ 0\\.0025169398126963782\ \(0\)\
\-\ \\)\\:\\ 0\\.002486194049175279\ \(0\)\
\-\ of\\:\\ 0\\.002435619528877807\ \(0\)\
\-\ \\.\\:\\ 0\\.0014843011608646527\ \(0\)\
\-\ with\\:\\ 0\\.001223040168187001\ \(0\)\
